Avaaz-Taking Action Against Unjust Decisions

Avaaz is gaining a global voice and is continuously adding members to its cause. Avaaz was founded in 2007 and is just five years old but has grown to be a globally-known force against many of the injustices of the world.

Avaaz means “voice” in several Asian, European, and Middle Eastern languages and has a simple mission. Avaaz is all for closing the gap between the world we live in and the world we all want. Avaaz is empowering people all over the world to have a say in the way things are run and in decisions that are being made by governments all over the world.

Avaaz has been able to organize millions of people to take action against the national, regional, and global issues of our world. Avaaz takes action by emailing, signing petitions, funding media campaigns, lobbying and calling governments, and organizing protests. Avaaz is making sure that the values and views of the people are heard by those in power.

Avaaz campaigns in as many as 15 different languages and has a core team on six continents. Avaaz is also made up of thousands of volunteers.

Avaaz was founded by Ricken Patel, the Canadian-British founding president. He previously worked for the International Crises Group, where he picked up many useful tools such as how to effectively negotiate.

Avaaz is managed by a team that works from over 30 different countries, including Brazil, the UK, Lebanon, and India. Member communicate through emails, videos and also use advertisements and commissions in order to receive legal advice pertaining to campaigns.

Avaaz wants to unite idealists from all over the world in order to make a difference in what happens and what decisions are made. Avaaz many progressive causes such as challenging Montsanto, climate change issues, and support for refugees.

CLC Foundation Board Chair Honored with Golf Classic

A recent organ transplant provided second chance for

Chris Piazzi, whom is the president of Mundelein Community Bank and whom also serves as chair of the College of Lake County Foundation Board came to the Cancer Treatment Centers of America in February for an organ transplant.

Piazzi came in for a necessary double transplant of both his liver and kidney. The operation was successful and saved his life.

With such a successful operation the Foundation Board of College of Lake County will be hosting a Scholarship Golf Classic that will honor Piazzi’s successful operation and his dedicated service to their foundation. The Golf Classic will be held on June 12, 2017 at the Ivanhoe Golf Club in Mundelein.

The funds raised will provide scholarships to local students. The College of Lake County Foundation was able to provide 386 students paths to more promising futures and raised a total of over $951,000 in scholarship funds.

The Golf Classic will be chaired by an elite steering committee including Dave Galla, Pete Govorchin, Rob Hauswirth, Michael Isaacs, Steve Rankins and Bob Werdan.

Anyone interested in supporting the event can learn more about it or register at https://foundation.clcillinois.edu/golfsponsor2017 or call Kristen Davis at (847) 543-2400.

The Cancer Treatment Centers of America prides itself on a dedicated to genuine patient care that is focused on the specific patient. The team at Cancer Treatment Centers of America has a team of top-qualified experts in the field that focus only on treating cancer and that are dedicated to cutting edge research and technology to stay atop of every stage of the disease.

Cancer Treatment Centers of America utilizes the latest technology and a team-centric approach to make sure each patient receives the upmost in care and service from their team of doctors and clinicians.

For more information follow CTCA on Twitter.

The Cancer Treatment Centers of America (CTCA) Spice Up Its Services by Implementing the Clinical Pathway Program

CTCA has joined hands with Allscripts Sunrise and NantHealth to roll out the Clinical Pathways program. The program will link up NantHealth’s eviti® solutions and Allscript’s electronic health record (HER), thus enhancing an efficient cancer treatment process and smooth delivery of clinical services by medical practitioners. NantHealth brought with it a clinical operating system, NantOS that incorporates a database for cancer care.

Benefits to Patients

As stated in this article, Clinical Pathways will integrate a compilation of cancer research reports from oncologists drawn from across the United States and beyond. These reports improve cancer treatment, which makes them the best patient-centered medical advancement in the recent times. This integration will also link up patients and medical practitioners as well as individual partner patients with the clinical teams that they may require. With this kind of partnership, patients will have a clear understanding of their diagnosis and treatment process. On top of that, Clinical Pathways will provide patient treatment data to health insurance providers to hasten insurance approval when the need arises. Patients at any of the five CTCA hospitals will have access to these services.

Benefits to Physicians

According to Wikipedia, physicians will also have their fair share of benefits from Clinical Pathways. The program will offer them a platform to solicit reliable and accurate medical information from Evidence-Based Medical Library. The library has more than 2,700 cancer treatment prescriptions and regimens compiled from government agencies and oncology associations. These regimens details expected treatment costs and clinical outcomes.

About CTCA

CTCA is a conglomeration of five hospitals that specializes in cancer treatment across the U.S. Founded by Richard Stephenson in 1988, the organization was initially headquartered in Illinois but was later moved to Boca Raton, Florida.

During the first 17 years, the organization was operating in only one hospital: the Midwestern Regional Medical Center in Illinois. The other four hospitals have been established in four different states, including Pennsylvania, Oklahoma, Arizona, and Georgia.

For more information on CTCA follow them on Facebook and Twitter.

Dr. Scott Rocklage is a Seasoned Scientist with a Heart for Charity Work

Dr. Scott Rocklage is a trained chemist and a leader of 5 AM Ventures’ management committee. He joined the 5 AM Ventures’ leadership team as a partner and worked his way up to the senior partner post. Dr. Rocklage majored in chemistry during his bachelor’s degree level at the University of California. He undertook his Ph.D. at Massachusetts Institute of Technology. While conducting his doctoral studies, he worked in the lab of the Nobel Prize honoree Richard Schrock. Dr. Rocklage is married to Patty Rocklage, who is an accomplished marriage and family counselor. They live together in Sudbury, Massachusetts.

 

Dr. Rocklage’s career history, contributions, and achievements

 

Dr. Rocklage is a seasoned scientist with an extensive experience in the field of research. At the start of his career, he held various management positions in different pharmaceutical firms. Dr. Rocklage was the senior principal of EPIRUS Pharmaceuticals, Inc. He was also the CEO of Amersham Health, Ilypsa Inc., Cubist Pharmaceuticals, and Nycomed Salutar Inc. Dr. Rocklage began working with Nycomed in 1992 as its executive officer. He later became president and the board chairperson of the company. Dr. Rocklage is a committed member of the Board of Cidara Therapeutics Inc., Novira Therapeutics Inc., Rennovia Inc., Pulmatrix Inc., and Kinestral Inc. He guides companies like WaveRx, Whitehead Institute, and Semprus by serving as a board member

 

Dr. Scott Rocklage recently donated a huge lump sum of cash to his former college to aid in the construction of high-tech laboratories. Dr. Rocklage and his wife gave out $250,000 to assist with the renovation costs. After the construction was complete, they were celebrated during the commissioning of the buildings. Dr. Rocklage and his wife took a tour around the labs together with Bawendi and his students. They were paid tribute by Sylvia Ceyer and her colleagues at the Department of Chemistry. Throughout his career, Dr. Rocklage has acquired extensive work experience in the fields of science, research, management and leadership. Dr. Rocklage has assisted in the development and licensing of over 30 U.S. patents. He has also published over 100 peer-reviewed articles.